ALK and ROS1 rearrangements, coexistence and treatment in epidermal growth factor receptor-wild type lung adenocarcinoma: a multicenter study of 732 cases.

导出 OA

翻译打印收藏纠错

第一作者： Zhengbo,Song

第一单位： Department of Respiratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, China.

作者： Zhengbo,Song ^[1] ; Yuhui,Zheng ^[2] ; Xuzhou,Wang ^[3] ; Haiyan,Su ^[4] ; Yiping,Zhang ^[5] ; Yong,Song ^[2]

作者单位： Department of Respiratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, China. ^[1] Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou 310022, China. ^[2] Department of Pathology, Union Hospital, Fujian Medical University, Fuzhou 350001, China. ^[3] Department of Pathology, Fuzhou General Hospital of Nanjing Military Command, Fuzhou 350025, China. ^[4] Department of Pathology, Municipal Hospital of Fujian Province, Zhangzhou 363000, China. ^[5]

关键词 Lung adenocarcinoma anaplastic lymphoma kinase (ALK)c-ros oncogene 1 (ROS1)epidermal growth factor receptor (EGFR)frequency, coexistence, efficacy

DOI 10.21037/jtd.2017.09.79

PMID 29268402

发布时间 2022-03-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交